148 related articles for article (PubMed ID: 22290723)
1. Association of glycosylated hemoglobin with the gene encoding CDKAL1 in the Korean Association Resource (KARE) study.
Ryu J; Lee C
Hum Mutat; 2012 Apr; 33(4):655-9. PubMed ID: 22290723
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of genetic associations of CDKAL1 and HHEX with susceptibility of type 2 diabetes mellitus by gender.
Ryoo H; Woo J; Kim Y; Lee C
Eur J Hum Genet; 2011 Jun; 19(6):672-5. PubMed ID: 21368910
[TBL] [Abstract][Full Text] [Related]
3. Association of a cyclin-dependent kinase 5 regulatory subunit-associated protein 1-like 1 (CDKAL1) polymorphism with elevated hemoglobin A₁(c) levels and the prevalence of metabolic syndrome in Japanese men: interaction with dietary energy intake.
Miyaki K; Oo T; Song Y; Lwin H; Tomita Y; Hoshino H; Suzuki N; Muramatsu M
Am J Epidemiol; 2010 Nov; 172(9):985-91. PubMed ID: 20847106
[TBL] [Abstract][Full Text] [Related]
4. Investigation of type 2 diabetes risk alleles support CDKN2A/B, CDKAL1, and TCF7L2 as susceptibility genes in a Han Chinese cohort.
Wen J; Rönn T; Olsson A; Yang Z; Lu B; Du Y; Groop L; Ling C; Hu R
PLoS One; 2010 Feb; 5(2):e9153. PubMed ID: 20161779
[TBL] [Abstract][Full Text] [Related]
5. Adaptive human CDKAL1 variants underlie hormonal response variations at the enteroinsular axis.
Chang CL; Cai JJ; Huang SY; Cheng PJ; Chueh HY; Hsu SY
PLoS One; 2014; 9(9):e105410. PubMed ID: 25222615
[TBL] [Abstract][Full Text] [Related]
6. Polycystic ovary syndrome is not associated with polymorphisms of the TCF7L2, CDKAL1, HHEX, KCNJ11, FTO and SLC30A8 genes.
Kim JJ; Choi YM; Cho YM; Hong MA; Chae SJ; Hwang KR; Hwang SS; Yoon SH; Moon SY
Clin Endocrinol (Oxf); 2012 Sep; 77(3):439-45. PubMed ID: 22443257
[TBL] [Abstract][Full Text] [Related]
7. Replication study of novel risk variants in six genes with type 2 diabetes and related quantitative traits in the Han Chinese lean individuals.
Bao XY; Peng B; Yang MS
Mol Biol Rep; 2012 Mar; 39(3):2447-54. PubMed ID: 21643948
[TBL] [Abstract][Full Text] [Related]
8. Trans-ethnic fine mapping identifies a novel independent locus at the 3' end of CDKAL1 and novel variants of several susceptibility loci for type 2 diabetes in a Han Chinese population.
Kuo JZ; Sheu WH; Assimes TL; Hung YJ; Absher D; Chiu YF; Mak J; Wang JS; Kwon S; Hsu CC; Goodarzi MO; Lee IT; Knowles JW; Miller BE; Lee WJ; Juang JM; Wang TD; Guo X; Taylor KD; Chuang LM; Hsiung CA; Quertermous T; Rotter JI; Chen YD
Diabetologia; 2013 Dec; 56(12):2619-28. PubMed ID: 24013783
[TBL] [Abstract][Full Text] [Related]
9. Positive Association Between Type 2 Diabetes Risk Alleles Near CDKAL1 and Reduced Birthweight in Chinese Han Individuals.
Sun XF; Xiao XH; Zhang ZX; Liu Y; Xu T; Zhu XL; Zhang Y; Wu XP; Li WH; Zhang HB; Yu M
Chin Med J (Engl); 2015 Jul; 128(14):1873-8. PubMed ID: 26168825
[TBL] [Abstract][Full Text] [Related]
10. CDKAL1 gene rs7756992 A/G polymorphism and type 2 diabetes mellitus: a meta-analysis of 62,567 subjects.
Li YY; Wang LS; Lu XZ; Yang ZJ; Wang XM; Zhou CW; Xu J; Qian Y; Chen AL
Sci Rep; 2013 Nov; 3():3131. PubMed ID: 24185407
[TBL] [Abstract][Full Text] [Related]
11. Positive association between variations in CDKAL1 and type 2 diabetes in Han Chinese individuals.
Liu Y; Yu L; Zhang D; Chen Z; Zhou DZ; Zhao T; Li S; Wang T; Hu X; Feng GY; Zhang ZF; He L; Xu H
Diabetologia; 2008 Nov; 51(11):2134-7. PubMed ID: 18766326
[No Abstract] [Full Text] [Related]
12. A cautionary tale: the non-causal association between type 2 diabetes risk SNP, rs7756992, and levels of non-coding RNA, CDKAL1-v1.
Locke JM; Wei FY; Tomizawa K; Weedon MN; Harries LW
Diabetologia; 2015 Apr; 58(4):745-8. PubMed ID: 25634229
[TBL] [Abstract][Full Text] [Related]
13. Dietary Protein and Fat Intake Affects Diabetes Risk with
Choi WJ; Jin HS; Kim SS; Shin D
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32764395
[TBL] [Abstract][Full Text] [Related]
14. The CDKAL1 gene is associated with impaired insulin secretion and glucose-related traits: the Cardiometabolic Risk in Chinese (CRC) study.
Liang J; Pei Y; Liu X; Qiu Q; Sun Y; Zhu Y; Yang M; Qi L
Clin Endocrinol (Oxf); 2015 Nov; 83(5):651-5. PubMed ID: 26119585
[TBL] [Abstract][Full Text] [Related]
15. Implication of genetic variants near TCF7L2, SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, and FTO in type 2 diabetes and obesity in 6,719 Asians.
Ng MC; Park KS; Oh B; Tam CH; Cho YM; Shin HD; Lam VK; Ma RC; So WY; Cho YS; Kim HL; Lee HK; Chan JC; Cho NH
Diabetes; 2008 Aug; 57(8):2226-33. PubMed ID: 18469204
[TBL] [Abstract][Full Text] [Related]
16. Genetic variants on chromosome 6p21.1 and 6p22.3 are associated with type 2 diabetes risk: a case-control study in Han Chinese.
Lu F; Qian Y; Li H; Dong M; Lin Y; Du J; Lin Y; Chen J; Shen C; Jin G; Dai J; Hu Z; Shen H
J Hum Genet; 2012 May; 57(5):320-5. PubMed ID: 22437209
[TBL] [Abstract][Full Text] [Related]
17. Association between polymorphisms in SLC30A8, HHEX, CDKN2A/B, IGF2BP2, FTO, WFS1, CDKAL1, KCNQ1 and type 2 diabetes in the Korean population.
Lee YH; Kang ES; Kim SH; Han SJ; Kim CH; Kim HJ; Ahn CW; Cha BS; Nam M; Nam CM; Lee HC
J Hum Genet; 2008; 53(11-12):991-998. PubMed ID: 18991055
[TBL] [Abstract][Full Text] [Related]
18. Variants of the PPARG, IGF2BP2, CDKAL1, HHEX, and TCF7L2 genes confer risk of type 2 diabetes independently of BMI in the German KORA studies.
Herder C; Rathmann W; Strassburger K; Finner H; Grallert H; Huth C; Meisinger C; Gieger C; Martin S; Giani G; Scherbaum WA; Wichmann HE; Illig T
Horm Metab Res; 2008 Oct; 40(10):722-6. PubMed ID: 18597214
[TBL] [Abstract][Full Text] [Related]
19. The carriage of risk variants of CDKAL1 impairs beta-cell function in both diabetic and non-diabetic patients and reduces response to non-sulfonylurea and sulfonylurea agonists of the pancreatic KATP channel.
Chistiakov DA; Potapov VA; Smetanina SA; Bel'chikova LN; Suplotova LA; Nosikov VV
Acta Diabetol; 2011 Sep; 48(3):227-35. PubMed ID: 21611789
[TBL] [Abstract][Full Text] [Related]
20. Single-nucleotide polymorphism rs7754840 of CDKAL1 is associated with impaired insulin secretion in nondiabetic offspring of type 2 diabetic subjects and in a large sample of men with normal glucose tolerance.
Stancáková A; Pihlajamäki J; Kuusisto J; Stefan N; Fritsche A; Häring H; Andreozzi F; Succurro E; Sesti G; Boesgaard TW; Hansen T; Pedersen O; Jansson PA; Hammarstedt A; Smith U; Laakso M;
J Clin Endocrinol Metab; 2008 May; 93(5):1924-30. PubMed ID: 18285412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
